Madrigal Pharmaceuticals, Inc. company logo
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) Cash From Operations

Annual CFO

-$455.57M$131.34M-40.51%

Summary

Current Value
As of today, MDGL annual cash from operations is -$455.57M, down -40.51% on
Historical Performance
MDGL annual cash from operations is down -147.71% over the past 3 years, and down -994.49% over the past 5 years
All-Time High Comparison
MDGL annual cash from operations is currently -1773.54% below its historical high of $27.22M set on
3-Year Low Comparison
MDGL annual cash from operations is at its 3-year low
Sector Comparison
MDGL annual cash from operations is higher than 0.85% of companies in Healthcare sector

Cash From Operations Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MDGL Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Operations-$455.57M-40.5%-147.7%-994.5%-1599.3%
Quarterly Cash From Operations$79.85M+219.2%+235.2%+266.9%+1047.8%
TTM Cash From Operations-$160.58M+62.7%+25.1%-39.8%-331.1%
Price$510.53+50.6%+69.7%+356.2%+116.1%
Annual Cash From Investing-$274.39M+45.4%-5328.0%-993.6%-1403.6%
Annual Cash From Financing$735.06M+23.5%+329.3%+10000.0%+10000.0%
Annual Free Cash Flow-$462.03M-41.9%-150.9%-1005.5%-1594.7%
Annual CAPEX$6.46M+336.9%+2991.9%+3657.0%+1323.3%
Annual Net Income-$465.89M-24.7%-92.6%-455.0%-689.1%

Cash From Operations Highs

MDGL Annual Cash From Operations Highs Comparison
PeriodHighDateCurrent
3Y-$224.86MN/A-102.6%
5Y-$157.56MN/A-189.1%
All$27.22M-1773.5%

Cash From Operations Lows

MDGL Annual Cash From Operations Lows Comparison
PeriodLowDateCurrent
3Y-$455.57Mat low
5Y-$455.57Mat low
All-$455.57Mat low

Cash From Operations History

YearValueChange
-$455.57M-40.5%
-$324.23M-44.2%
-$224.86M-22.3%
-$183.92M-16.7%
-$157.56M-278.5%
-$41.62M-63.2%
-$25.51M-14.3%
-$22.32M-26.7%
-$17.61M-460.4%
-$3.14M+96.0%
-$78.93M-2.0%
YearValueChange
-$77.41M-43.0%
-$54.14M-14.5%
-$47.30M-23.8%
-$38.20M-42.5%
-$26.81M+29.3%
-$37.94M-239.4%
$27.22M+151.4%
-$52.99M+14.4%
-$61.88M-83.1%
-$33.80M-43.1%
-$23.61M-

FAQ

  • What is the current annual cash from operations of MDGL?

    As of today, MDGL annual cash from operations is -$455.57M

  • What is 1-year change in MDGL annual cash from operations?

    MDGL annual cash from operations is down -40.51% year-over-year

  • What is 3-year change in MDGL annual cash from operations?

    MDGL annual cash from operations is down -147.71% over the past 3 years

  • How far is MDGL annual cash from operations from its all-time high?

    MDGL annual cash from operations is currently -1773.54% below its historical high of $27.22M set on December 31, 2007

  • How does MDGL annual cash from operations rank versus sector peers?

    MDGL annual cash from operations is higher than 0.85% of companies in Healthcare sector

  • When is MDGL next annual earnings release?

    The next annual earnings release for MDGL is on

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In

Data Sources & References

  1. MDGL Official Website www.madrigalpharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828025048559/0001628280-25-048559-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828025007980/0001628280-25-007980-index.htm
  4. MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
  5. MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl